No Data
No Data
Maxim Group Keeps Their Buy Rating on Petros Pharmaceuticals (PTPI)
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Why Corvus Pharmaceuticals Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket
Proprietary Technology Addressing the Rx-to-OTC Switch Self-Care Market Valued at Over $38 Billion Annually
Petros Pharmaceuticals Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
US Manufacturing Index Rises To 43, Highest Since 2020
No Data